D. Strauß
Royal Marsden NHS Foundation Trust · 460 works · 13,533 citations · h-index 56
Top works
- Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS)
- Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
- Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis
- Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
- Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG
- Overview of the ITER EC upper launcher
- Surgical management of primary retroperitoneal sarcoma
- Transmission of donor melanoma by organ transplantation
- Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
- Endovascular Treatment of Penetrating Thoracic Outlet Arterial Injuries
- Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
- Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma
- Progress of the ECRH Upper Launcher design for ITER
- Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
- Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma
- Overview of the ITER EC H&CD system and its capabilities
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- Retroperitoneal tumours: review of management